Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126849933 | 12684993 | 3 | F | 2014 | 20160905 | 20160825 | 20160912 | EXP | JP-009507513-1608JPN010852 | MERCK | 0.00 | F | Y | 0.00000 | 20160912 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126849933 | 12684993 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | DAILY DOSAGE UNKNOWN | 21995 | TABLET | |||||||||
126849933 | 12684993 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | DAILY DOSAGE UNKNOWN | 21995 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126849933 | 12684993 | 1 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126849933 | 12684993 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126849933 | 12684993 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126849933 | 12684993 | 1 | 2012 | 0 |